VGXI, Inc. is a leading manufacturer of DNA plasmids. We deliver flexibility, experience, reliability and value to our clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews. VGXI’s patented manufacturing process and cGMP production facilities give us the ability to work with your unique requirements. The unsurpassed knowledge and ingenuity of our team can be leveraged to create a custom manufacturing solution for the benefit of your organization.
Blogroll
-
Join 3 other subscribers
2011 Vaccine Conferences
- 24 – 26 January, 2011: Phacilitate Vaccine Forum, Washington, D.C., USA
- 27 – 30 January, 2011: Controversies in Vaccination in Adults (CoVAC), Berlin, DE
- 10 – 11 February, 2011: Vaccine Research & Innovation 2011, London, UK
- 24 – 25 February, 2011: Next Generation Vaccines, Vienna, AT
- 14 – 18 March, 2011: Biopharmaceutical Development and Production Week, Bellevue, WA, USA
- 23 – 25 March, 2011: BIT’s 3rd Annual World Vaccine Congress, Beijing, CN
- 18 – 21 May, 2011: American Society of Gene and Cell Therapy, Seattle, WA, USA
- 6 – 8 June, 2011: Vaccine Production Summit, Boston, MA, USA
- 27 – 30 June, 2011: BIO International Convention, Washington, D.C., USA
- 12 – 14 July, 2011: DNA Vaccines 2011, San Diego, CA, USA
- 31 October – 4 November, 2011: BioProcess International, Long Beach, CA, USA